TrialClinical and translational science2025

Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2- Metastatic Breast Cancer Data From the Phase 3 TROPiCS-02 Trial.

Abhishek G Sathe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.